1. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser. 1972; 498:1–25.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998; 279:1200–1205.
Article
3. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004; 329:15–19.
Article
4. Bowman L, Carlstedt BC, Black CD. Incidence of adverse drug reactions in adult medical inpatients. Can J Hosp Pharm. 1994; 47:209–216.
5. Lundkvist J, Jönsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004; 18:275–280.
Article
6. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med. 2007; 167:1752–1759.
Article
7. Demoly P, Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol. 2001; 1:305–310.
Article
8. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998; 316:1295–1298.
9. Kim MH, Jung HY, Sohn MK, Kim SE, Lee YW, Park JW, et al. Clinical features of adverse drug reactions in a tertiary care hospital in Korea. Korean J Asthma Allergy Clin Immunol. 2008; 28:35–39.
10. Kim MG, Kang HR, Kim JH, Ju YS, Park SH, Hwang YIl, et al. Analysis of adverse drug reactions collected by an electronic reporting system in a single hospital. Korean J Med. 2009; 77:601–609.
11. Kim JE, Kyun JO, Jin SM, Lee YH, Kim JH, Lee HY, et al. Adverse drug reactions in elderly inpatients: comparison with younger patients. Korean J Asthma Allergy Clin Immunol. 2010; 30:216–221.
12. Choi JH, Shin YS, Suh CH, Nahm DH, Park HS. The frequency of adverse drug reactions in a tertiary care hostpital in Korea. Korean J Med. 2004; 67:290–296.
13. Rew SY, Koh YI, Shin HY, Park SH, Ryu SH, Kim HN, et al. Reporting and clinical features of adverse drug reactions from a single university hospital. Korean J Asthma Allergy Clin Immunol. 2011; 31:184–191.
14. Kos M, Wertheimer AI, Mrhar A. Satisfaction with pharmacotherapy for approved and off-label indications: a Delphi study. Ann Pharmacother. 2005; 39:649–654.
Article
15. Geum MJ, Park EH, Ko JH, Kim SH, Kim SE, Seok HJ. Case analysis of adverse drug reaction for children in Yonsei University Healthcare System. J Korean Soc Health Syst Pharm. 2011; 28:253–261.
Article
16. Coté CJ, Karl HW, Notterman DA, Weinberg JA, McCloskey C. Adverse sedation events in pediatrics: analysis of medications used for sedation. Pediatrics. 2000; 106:633–644.
17. Malviya S, Voepel-Lewis T, Prochaska G, Tait AR. Prolonged recovery and delayed side effects of sedation for diagnostic imaging studies in children. Pediatrics. 2000; 105:E42.
Article
18. Kim HM, Seong JM, Yang BR, Jin XM, Choi NK, Lee J, et al. Analysis of adverse events reporting patterns and signal detection for pediatric patients in the Korean spontaneous reporting data. Korean Soc Pharmacoepidemiol Risk Manage. 2012; 5:40–45.
19. Ferrajolo C, Capuano A, Trifirò G, Moretti U, Rossi F, Santuccio C. Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 - 2012. Expert Opin Drug Saf. 2014; 13:Suppl 1. S9–S20.
Article
20. Park GM, Seo JH, Kim HY, Yu J, Hong SJ. Four cases of drug allergy caused by non-steroidal anti-inflammatory drugs in children. Pediatr Allergy Respir Dis. 2011; 21:344–349.
Article
21. Mirakian R, Ewan PW, Durham SR, Youlten LJ, Dugué P, Friedmann PS, et al. BSACI guidelines for the management of drug allergy. Clin Exp Allergy. 2009; 39:43–61.
Article
22. Jung JH, Kim JT, Yoo KY. Assessment of pediatric adverse drug reaction reports. J Korean Soc Health Syst Pharm. 2013; 30:108–118.
Article